Ixerochinoside



Compound IDCDAMM02277
Common nameIxerochinoside
IUPAC name[3,4,5-trihydroxy-6-[[4-[2-(4-hydroxyphenyl)acetyl]oxy-3,6,9-trimethylidene-2-oxo-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-8-yl]oxy]oxan-2-yl]methyl 2-(4-hydroxyphenyl)acetate
Molecular formulaC37H40O13

Experimental data

Retention time0.41
Adduct[M+H]+
Actual mz693.253
Theoretical mz693.254
Error1.26
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.4483

Identifiers and class information

Inchi keyHMUFZGUGGDDWBV-WGNCPBMBNA-N
SmilesO=C1OC2C(C1=C)C(OC(=O)CC3=CC=C(O)C=C3)CC(=C)C4CC(OC5OC(COC(=O)CC6=CC=C(O)C=C6)C(O)C(O)C5O)C(=C)C24
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)5
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)15
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)692.715
Computed dipole moment(dipole)6.619
Total solvent accessible surface area (SASA)898.755
Hydrophobic component of SASA (FOSA)344.917
Hydrophilic component of SASA (FISA)281.039
Pie component of the SASA (PISA)272.8
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1876.85
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)17
Free energy of solvation of dipole (dip^2/V)0.0233428
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0422953
Globularity descriptor (glob)0.818736
Predicted polarizability in cubic angstroms (QPpolrz)61.931
Predicted hexadecane/gas partition coefficient (QPlogPC16)20.295
Predicted octanol/gas partition coefficient (QPlogPoct)38.361
Predicted water/gas partition coefficient (QPlogPw)26.408
Predicted octanol/water partition coefficient (QPlogPo/w)2.012
Predicted aqueous solubility (QPlogS)-4.125
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.051
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.766
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)21.42
Predicted brain/blood partition coefficient (QPlogBB)-3.136
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)7.765
Predicted skin permeability, log Kp (QPlogKp)-4.298
PM3 calculated ionization potential (IP(ev))9.138
PM3 calculated electron affinity (EA(eV))0.259
Number of likely metabolic reactions (#metab)12
Prediction of binding to human serum albumin (QPlogKhsa)-0.207
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)36.627
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)217.002
Number of nitrogen and oxygen atoms (#NandO)13
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2

Copyright © 2025